A. Hamilton

674 total citations
15 papers, 513 citations indexed

About

A. Hamilton is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, A. Hamilton has authored 15 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in A. Hamilton's work include Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (4 papers) and Urinary Tract Infections Management (3 papers). A. Hamilton is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (4 papers) and Urinary Tract Infections Management (3 papers). A. Hamilton collaborates with scholars based in United States, Denmark and Belgium. A. Hamilton's co-authors include Martine Piccart, Franco M. Muggia, N. Wilcken, Anna K. Nowak, Davina Ghersi, Angelo Di Leo, Allan J. Jacobs, Eleni Andreopoulou, John P. Curtin and D. Mirchandani and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

A. Hamilton

14 papers receiving 499 citations

Peers

A. Hamilton

ONCOL

RNMI

BIOMA

Elisa De Camilli Italy

Mariagrazia Ruvoletto Italy

Zhongzhen Guan China

Rekha Samuel United States

Andrew Cannon United States

Valeria Quaranta Italy

Matthew Volm United States

Emma Kipps United Kingdom

Elisa De Camilli Italy

A. Hamilton

133 ×0.4

ONCOL

156 ×1.0

126 ×0.9

53 ×0.8

RNMI

36 ×0.7

BIOMA

Citations per year, relative to A. Hamilton A. Hamilton (= 1×) peers Elisa De Camilli

Countries citing papers authored by A. Hamilton

Since Specialization

Citations

This map shows the geographic impact of A. Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hamilton more than expected).

Fields of papers citing papers by A. Hamilton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hamilton. The network helps show where A. Hamilton may publish in the future.

Co-authorship network of co-authors of A. Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hamilton. A scholar is included among the top collaborators of A. Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hamilton. A. Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

L, Liu, Lena L. Rosenbæk, A. Hamilton, et al.. (2025). Renal Ghrelin-Family GPR39 Receptor and Urinary Concentrating Ability. Journal of the American Society of Nephrology. 36(8). 1548–1560.

Hamilton, A. & Helle A. Prætorius. (2024). Reduced graft survival in renal transplant patients with urinary tract infections – a meta-analysis. PubMed. 71(2). 1–12. 2 indexed citations

Christensen, Mette, et al.. (2020). Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in A Murine Model of Urosepsis. International Journal of Molecular Sciences. 21(16). 5652–5652. 4 indexed citations

Hamilton, A., et al.. (2019). α‐Haemolysin production, as a single factor, causes fulminant sepsis in a model ofEscherichia coli‐induced bacteraemia. Cellular Microbiology. 21(6). e13017–e13017. 19 indexed citations

Andreopoulou, Eleni, D. Mirchandani, A. Hamilton, et al.. (2007). Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil®): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer. Annals of Oncology. 18(4). 716–721. 58 indexed citations

Millward, Michael, A. Hamilton, Damien Thomson, Anand M. Gautam, & Elena Wilson. (2007). Final results of a phase I study of daily PI-88 as a single agent and in combination with dacarbazine (D) in patients with metastatic melanoma. Journal of Clinical Oncology. 25(18_suppl). 8532–8532. 5 indexed citations

Mulkerin, Daniel, Scot C. Remick, Rajeev Ramanathan, et al.. (2006). A dose-escalating and pharmacologic study of bortezomib in adult cancer patients with impaired renal function. Journal of Clinical Oncology. 24(18_suppl). 2032–2032. 17 indexed citations

Nowak, Anna K., et al.. (2004). Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer. The Lancet Oncology. 5(6). 372–380. 91 indexed citations

Pavlick, Anne C., Michael Millward, Kathleen Farrell, et al.. (2004). A phase II study of epothilone B analog (EpoB)-BMS 247550 (NSC#710428) in stage IV malignant melanoma (MM). Journal of Clinical Oncology. 22(14_suppl). 7542–7542. 21 indexed citations

10.

Pavlick, Anne C., Kathleen Farrell, A. Hamilton, et al.. (2004). A phase II study of epothilone B analog (EpoB)-BMS 247550 (NSC#710428) in stage IV malignant melanoma (MM). Journal of Clinical Oncology. 22(14_suppl). 7542–7542. 7 indexed citations

11.

Biganzoli, Laura, Tanja Čufer, Peter F. Bruning, et al.. (2002). Doxorubicin‐paclitaxel. Cancer. 97(1). 40–45. 30 indexed citations

12.

Muggia, Franco M. & A. Hamilton. (2001). Phase III data on Caelyx® in ovarian cancer. European Journal of Cancer. 37. 15–18. 44 indexed citations

13.

Hamilton, A., Denis Larsimont, Robert Paridaens, et al.. (2000). A Study of the Value of p53, HER2, and Bcl-2 in the Prediction of Response to Doxorubicin and Paclitaxel as Single Agents in Metastatic Breast Cancer: A Companion Study to EORTC 10923. Clinical Breast Cancer. 1(3). 233–240. 42 indexed citations

14.

Piccart, Martine, Angelo Di Leo, & A. Hamilton. (2000). HER2. European Journal of Cancer. 36(14). 1755–1761. 41 indexed citations

15.

Hamilton, A. & Martine Piccart. (2000). The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53 and BCL-2. Annals of Oncology. 11(6). 647–663. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact